ET, W., D, C., K, S., C, D., P, S., JE, D., . . . A, M. (2025). IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: Overcoming the logistic challenge. Frontiers in oncology, 15, 1556450. https://doi.org/10.3389/fonc.2025.1556450
Chicago Style (17th ed.) CitationET, Wong, et al. "IGV-001 Cellular Immunotherapy for Newly Diagnosed Glioblastoma: Overcoming the Logistic Challenge." Frontiers in Oncology 15 (2025): 1556450. https://doi.org/10.3389/fonc.2025.1556450.
MLA (9th ed.) CitationET, Wong, et al. "IGV-001 Cellular Immunotherapy for Newly Diagnosed Glioblastoma: Overcoming the Logistic Challenge." Frontiers in Oncology, vol. 15, 2025, p. 1556450, https://doi.org/10.3389/fonc.2025.1556450.
Warning: These citations may not always be 100% accurate.